fDi Markets Newswire:

View from BIO 2014

View from BIO 2014

Date: June 23 – 26, 2014
Location: San Diego Convention Centre, US

About 15,000 of the most powerful biotech and pharma players from 65 countries attended the 2014 BIO International Convention. Michal Kaczmarski, fDi Magazine's Americas & Europe editor, reported on the main topics of discussion and interviewed FDI and industry professionals.

View from BIO is your hub for the 2014 BIO International Convention, bringing you the latest coverage, FDI data and articles from the biotechnology industry.

Register here to receive daily updates from BIO 2014 and sign up to the fDi Intelligence e-newsletter.

Biotechnology FDI data

Between April 2009 and April 2014 a total of 410 FDI projects in the Biotechnology sector were recorded. These projects represent a total capital investment of $5.53bn which is an average investment of $70.80m per project. During the period, a total of 9,388 jobs were created.

BIO Data

Trends spotted using fDi Markets, an online database tracking crossborder greenfield investment, covering all sectors and countries worldwide. Contact us for more information.

Pre-BIO 2014 interview


Leipzig stands out from the automotive and biotech crowds

Leipzig stands out from the automotive and biotech crowds

Seemingly every FDI-hungry location in the world is eyeing the automotive and biotech sectors, but by focusing on the SME supply chain, the east German city of Leipzig is managing to excel in both areas.

Lower Saxony shows its biotech credentials

Lower Saxony shows its biotech credentials

The Lower Saxony region in Germany is home to the world's largest exhibition hall and an impressive biotech cluster, meaning that the region is becoming a must-visit destination for numerous big names in the industry.

Robert Collymore

View from the C-Suite: Is Safaricom the great leveller?

How do you ensure a country’s economic gains reach the poorest in the population? Robert Collymore, chief of telecoms firm Safaricom, believes he has the answer.